Nuvalent Reports Director Departure, New CMO Appointment
Ticker: NUVL · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1861560
Sentiment: neutral
Topics: management-change, executive-compensation
Related Tickers: NUVAL
TL;DR
Nuvalent's board sees a change with Dr. Evans out, Dr. Parkinson in as CMO, and exec comp details filed.
AI Summary
On June 9, 2025, Nuvalent, Inc. filed an 8-K to report changes in its board of directors and executive compensation. Specifically, the company announced the departure of director Dr. R. Brad Evans and the appointment of Dr. David R. Parkinson as Chief Medical Officer. The filing also details compensatory arrangements for certain officers.
Why It Matters
Changes in key leadership roles and executive compensation can signal shifts in company strategy or performance, impacting investor confidence and future operational direction.
Risk Assessment
Risk Level: medium — Changes in key executive and director positions can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Nuvalent, Inc. (company) — Registrant
- Dr. R. Brad Evans (person) — Departing Director
- Dr. David R. Parkinson (person) — Appointed Chief Medical Officer
- June 9, 2025 (date) — Date of earliest event reported
FAQ
Who has departed from Nuvalent's board of directors?
Dr. R. Brad Evans has departed from Nuvalent's board of directors.
Who has been appointed as the new Chief Medical Officer at Nuvalent?
Dr. David R. Parkinson has been appointed as the new Chief Medical Officer at Nuvalent.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 9, 2025.
What is Nuvalent's principal executive office address?
Nuvalent's principal executive office is located at One Broadway, 14th Floor, Cambridge, Massachusetts 02142.
What is Nuvalent's telephone number?
Nuvalent's telephone number is (857) 357-7000.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 by Dr. R. Brad Evans regarding Nuvalent, Inc. (NUVL).